DP Clinical has a breadth of experience in clinical trials involving ophthalmic drugs and devices. Sponsors from emerging biotechs to global pharmaceutical companies have trusted DP Clinical for 30 years to lead their ophthalmology development across a wide range of indications, and we have performed Phase II-IV studies ranging in size from 1 to 87 sites with anywhere from 20 to 1100 patients.

Our experienced teams are familiar with the various vision assessments used in ophthalmology studies; such as, optical coherence tomographic (OCT), fluorescein angiography, corneal and conjunctival straining, pachymetry, and gonioscopy. We have strong relationships with ophthalmic sites, investigators, and central reading centers that reduce startup time, afford strong communication, and ensure study success.

DP Clinical’s ophthalmology experience includes the following indications:

  • Acute Anterior Uveitis
  • Bacterial Conjunctivitis
  • Branch Retinal Vein Occlusion
  • Cataract Surgery
  • Conjunctivitis
  • Dry Eye
  • Glaucoma
  • Herpes Zoster Ophthalmicus (HZO)
  • Leber Hereditary Optic Neuropathy
  • Lid Inflammation
  • Macular Degeneration – Neovascular Age Related
  • Macular Edema Cystoid
  • Pediatric Amblyopia
  • Retinitis Pigmentosa